Editorial
doi: 10.1056/NEJMe048203.
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
- PMID: 15459307
- DOI: 10.1056/NEJMe048203
Item in Clipboard
Editorial
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
N Engl J Med.
.
No abstract available
Comment in
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675090 No abstract available.
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675092 No abstract available.
Comment on
-
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.N Engl J Med. 1999 Mar 11;340(10):764-71. doi: 10.1056/NEJM199903113401004. N Engl J Med. 1999. PMID: 10072411 Clinical Trial.
-
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446. N Engl J Med. 2004. PMID: 15459300 Clinical Trial.
Similar articles
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675092 No abstract available.
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. doi: 10.1056/NEJMicm041049. N Engl J Med. 2005. PMID: 15675093 No abstract available.
-
Caspofungin versus liposomal amphotericin B for empirical therapy.N Engl J Med. 2005 Jan 27;352(4):410-4; author reply 410-4. N Engl J Med. 2005. PMID: 15675091 No abstract available.
-
[Update on therapy of invasive mycoses in hematology and oncology].Dtsch Med Wochenschr. 2005 Jun 3;130(22):1381-4. doi: 10.1055/s-2005-868738. Dtsch Med Wochenschr. 2005. PMID: 15915381 Review. German. No abstract available.
-
Modern antifungal therapy for neutropenic fever.Curr Hematol Malig Rep. 2006 Jun;1(2):95-100. doi: 10.1007/s11899-006-0029-0. Curr Hematol Malig Rep. 2006. PMID: 20425338 Review.
Cited by
-
Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea.Yonsei Med J. 2014 Jan;55(1):9-18. doi: 10.3349/ymj.2014.55.1.9. Yonsei Med J. 2014. PMID: 24339281 Free PMC article.
-
Voriconazole in the management of nosocomial invasive fungal infections.Ther Clin Risk Manag. 2006 Jun;2(2):129-58. doi: 10.2147/tcrm.2006.2.2.129. Ther Clin Risk Manag. 2006. PMID: 18360588 Free PMC article.
-
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.Support Care Cancer. 2007 Feb;15(2):137-41. doi: 10.1007/s00520-006-0137-3. Epub 2006 Sep 12. Support Care Cancer. 2007. PMID: 16967301 Review.
-
Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.Curr Infect Dis Rep. 2008 Nov;10(6):459-65. doi: 10.1007/s11908-008-0075-y. Curr Infect Dis Rep. 2008. PMID: 18945386
-
Current and future therapeutic options in the management of invasive aspergillosis.Drugs. 2008;68(3):265-82. doi: 10.2165/00003495-200868030-00002. Drugs. 2008. PMID: 18257606 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
